All In Biotech

Free tool

FAERS Monitor: Indocin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018332 or its brand name (Indocin, Indomethacin). Reports on generic versions are filed under their own applications.

Reports

13,296

Serious

10,490

79% of reports

Hospitalization

4,486

Death reported

1,529

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,432
  • fatigue1,151
  • headache1,058
  • arthralgia1,036
  • off label use1,027
  • nausea949
  • pain944
  • diarrhoea906
  • dizziness894
  • dyspnoea770
  • vomiting760
  • asthenia658
  • pyrexia631
  • pruritus625
  • malaise619

Reports by year received

View as table
YearReports
2004358
2005372
2006391
2007385
2008356
2009408
2010374
2011486
2012702
2013430
2014395
2015555
2016681
2017592
2018740
2019820
2020640
2021755
20221,010
2023867
2024884
2025742
2026352

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,863 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
arthralgiaSignal1,0363.93.72,319
pyrexiaSignal6312.92.7789
dizzinessSignal8942.82.71,087
astheniaSignal6582.82.6755
headacheSignal1,0582.72.51,138
pruritusSignal6252.62.4611
vomitingSignal7602.62.4736
painSignal9442.42.3818
fatigueSignal1,1512.32.2915
malaiseSignal6192.22.1429
diarrhoeaSignal9062.22.1626
dyspnoeaSignal7702.22.0487
nausea9491.91.8417
off label use1,0271.91.8422
drug ineffective1,4321.71.6459

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.